We confirmed that S9 diluted to 1% had equivalent XO and total XOR activity to those in plasma of the patient before bariatric surgery with liver dysfunction (the same sample as P1 in Figure 3), whose serum AST and ALT levels were 66 IU/L and 138 IU/L, respectively (Figure 5C). This evidence concerns the gene GPT and Decreased liver function.